DrugPatentWatch Database Preview
Novitium Pharma Company Profile
What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has two approved drugs.
Summary for Novitium Pharma
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Novitium Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | DAPSONE | dapsone | TABLET;ORAL | 206505-001 | Dec 1, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novitium Pharma | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 209823-001 | Oct 23, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novitium Pharma | DAPSONE | dapsone | TABLET;ORAL | 206505-002 | Dec 1, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
